Ishaq HM, Mohammad IS, Guo H, Shahzad M, Hou YJ, Ma C et al (2017) Molecular estimation of alteration in intestinal microbial composition in Hashimotos thyroiditis patients
For systemic peptides like MOTS-c or SS-31 , the injection site matters less because the peptide enters systemic circulation regardless of where it is administered
Clinical trial data provides objective evidence about efficacy (24.2% weight loss at 48 weeks), safety (88.8% completion rate), side effects (peak at weeks 6-8, resolve by week 12 for most), and discontinuation outcomes (70-80% regain over 12-18 months, not immediately)
Our clinical team includes Aesthetic Injectors Rebecca Fant, MSN, FNP-C and Angela Hunsaker, RN